No formal drug/drug interaction studies with Plenaxis were performed. Cytochrome P-450 is not known to be involved in the metabolism of Plenaxis. Plenaxis is highly bound to plasma proteins (96 to 99%). Laboratory Tests Response to Plenaxis should be monitored by measuring serum total testosterone concentrations just prior to administration on Day 29 and every 8 weeks thereafter. Serum transaminase levels should be obtained before starting treatment with Plenaxis and periodically during treatment. Periodic measurement of serum PSA levels may also be considered.